Smith & Nephew presented results showing its Episode of Care Assurance Program reduces readmission rates for total joint arthroplasties by 97 percent.
Here are four takeaways:
1. Smith & Nephew’s eCAP combines the company’s hip and knee implants with its PICO Negative Pressure Wound Therapy and ACTICOAT Flex 7 Antimicrobial Barrier Dressing.
2. All of the products within the eCAP are applied post surgery to help protect the incision and provide an effective barrier to microbial contamination to help defend surgical site infections.
3. Throughout the past year, over 1,300 total joint arthroplasties have been performed under the eCAP. Smith & Nephew has seen two readmissions, resulting in a 0.14 percent rate. Readmission rates following total joint arthroplasties that are not performed under the eCAP can surge to 5.3 percent.
4. Smith & Nephew partnered with Provider PPI, a group purchasing organization, to administer its eCAP. Smith & Nephew’s program is now at 16 Provider PPI facilities across the U.S.
“As healthcare systems move from fee-for-service to pay-for-value, healthcare providers are increasing[ly] responsible for the episode of care for the patient,” Glenn Warner, president of Smith & Nephew U.S., said. “ECap can help enable providers to reduce costly readmissions after TJA by adding class-leading
wound care products to help manage surgical incisions. We are proud to support our customers with innovative programs that deliver improved care in a large-scale, real-world setting.”